Mandatory Joint Clinical Assessments Won’t Compromise HTA Quality Or Member State Decisions, Says Eurordis
Executive Summary
Eurordis, the network of rare disease patient organizations, has defended EU proposals on wider cooperation on health technology assessments and rejects complaints lodged by member states.